Grant Pickering of LeonaBio (LONA) awarded 28,000 stock options at $8.35

Rhea-AI Filing Summary

LeonaBio director Grant Pickering received a grant of stock options for 28,000 shares of common stock. The options have an exercise price of $8.35 per share and expire on June 22, 2036. All 28,000 options were outstanding after the transaction, held as a direct position.

The options will vest on the earlier of June 23, 2027 or the day immediately before the next annual stockholder meeting that occurs after June 22, 2026. The grant was made under LeonaBio’s Outside Director Compensation Policy, indicating it is part of routine director compensation rather than an open-market purchase.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider PICKERING GRANT

Role null

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Buy)	28,000	$0.00	--

Holdings After Transaction: Stock Option (Right to Buy) — 28,000 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Option grant size: 28,000 options Exercise price: $8.35 per share Underlying shares: 28,000 shares +4 more

7 metrics

Option grant size 28,000 options Stock Option (Right to Buy) granted to director

Exercise price $8.35 per share Conversion or exercise price of granted options

Underlying shares 28,000 shares Common Stock underlying the options

Expiration date June 22, 2036 Option term end date

Post-transaction derivative holdings 28,000 options Total options held after grant

Vesting date trigger June 23, 2027 Latest vesting date if earlier meeting does not occur

Alternative vesting trigger Before next annual meeting after June 22, 2026 Earlier vesting condition tied to stockholder meeting

Key Terms

Stock Option (Right to Buy), Outside Director Compensation Policy, vesting, underlying security

4 terms

Stock Option (Right to Buy) financial

"security_title: "Stock Option (Right to Buy)""

Outside Director Compensation Policy financial

"The option reported was granted pursuant to the terms of the Issuer's Outside Director Compensation Policy."

vesting financial

"The shares subject to the option will vest on the earlier of (i) June 23, 2027, or (ii) the day immediately before the date of the next annual meeting..."

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

underlying security financial

"underlying_security_title: "Common Stock", underlying_security_shares: "28000.0000""

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 06/24/2026 - 06:29 PM Accepted by SEC EDGAR 06/24/2026 - 06:28 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

PICKERING GRANT

(Last) (First) (Middle)

C/O LEONABIO, INC.

18706 NORTH CREEK PARKWAY, SUITE 104

(Street)

BOTHELL WASHINGTON 98011

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
LeonaBio, Inc. [ LONA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/23/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$8.35	06/23/2026		A		28,000		(1)	06/22/2036	Common Stock	28,000	$0	28,000	D

Explanation of Responses:

1. The shares subject to the option will vest on the earlier of (i) June 23, 2027, or (ii) the day immediately before the date of the next annual meeting of the Issuer's stockholders that occurs after June 22, 2026. The option reported was granted pursuant to the terms of the Issuer's Outside Director Compensation Policy.

	/s/ Mark Worthington, Attorney in fact for Grant Pickering	06/24/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did LeonaBio (LONA) director Grant Pickering report in this Form 4?

Grant Pickering reported receiving a grant of stock options for 28,000 shares of LeonaBio common stock. The options are a compensation award, not an open-market purchase, and give him the right to buy shares at a fixed $8.35 exercise price in the future.

What are the key terms of Grant Pickering’s LeonaBio stock option grant?

The grant covers 28,000 underlying shares of LeonaBio common stock at an exercise price of $8.35 per share. The options expire on June 22, 2036 and will vest based on time or the timing of a future annual stockholder meeting, whichever occurs earlier.

When do Grant Pickering’s LeonaBio stock options vest?

The options vest on the earlier of June 23, 2027 or the day immediately before LeonaBio’s next annual stockholder meeting that occurs after June 22, 2026. This time-based vesting schedule ties the award to ongoing board service and the company’s regular meeting cycle.

Is Grant Pickering’s LeonaBio Form 4 transaction a stock purchase or a compensation award?

The Form 4 reflects a compensation award, not an open-market stock purchase. Pickering received a grant of stock options with a $8.35 exercise price, issued under LeonaBio’s Outside Director Compensation Policy, which typically governs routine equity compensation for non-employee directors.

How many LeonaBio derivative securities does Grant Pickering hold after this Form 4?

After the reported transaction, Grant Pickering held 28,000 stock options directly. Each option relates to one share of LeonaBio common stock, giving him the right, once vested, to buy up to 28,000 shares at the preset $8.35 exercise price before expiration.